FDA Approved: FOSAPREPITANT — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for fosaprepitant filed by BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

SUPPL AP for FOSAPREPITANT (FOSAPREPITANT)